Keyphrases
Antitumor Activity
100%
Soft Tissue Sarcoma
100%
Thrombospondin-1 (TSP-1)
100%
Mimetic Peptide
100%
Tumor Response
40%
Cell Concentration
40%
Bolus
40%
Circulating Endothelial Cells
40%
Osteoarthritis
20%
Tumor Progression
20%
Clinical Significance
20%
Tolerability
20%
Cell Tumor
20%
Antiangiogenic
20%
Concentration-response
20%
Time to Progression
20%
Clinical Covariates
20%
Minimal Responses
20%
Keratitis
20%
Hemangiosarcoma
20%
Background Exposure
20%
Depot Formulation
20%
Toxicosis
20%
Peptide Formulation
20%
Owned Dogs
20%
Pharmacology, Toxicology and Pharmaceutical Science
Prospective Study
100%
Soft Tissue Sarcoma
100%
Thrombospondin 1
100%
Neoplasm
80%
Antitumor Activity
60%
Tolerability
20%
Toxic Injury
20%
Antiangiogenic
20%
Tumor Growth
20%
Osteoarthritis
20%
Angiosarcoma
20%
Keratitis
20%
Veterinary Science and Veterinary Medicine
Soft-Tissue Sarcoma
100%
Dog
100%
Neoplasm
71%
Osteoarthritis
14%
Angiosarcoma
14%
Toxic Injury
14%
Owned Dogs
14%